Utama › Gangguan Depresi Major › California › Chino
Kajian klinikal Gangguan Depresi Major di Chino, CA
6 kajian untuk Gangguan Depresi Major sedang mencari peserta di lokasi dalam dan sekitar Chino (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Mengambil pesertaFasa 2
- Inland Psychiatric Medical Group, Chino
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 2
- Inland Psychiatric Medical Group, Inc. - Chino, Chino
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Mengambil pesertaFasa 4
- Neurocrine Clinical Site, Chino
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Mengambil pesertaFasa 2
- Seaport Investigator Site, Chino
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Mengambil pesertaFasa 3
- Neurocrine Clinical Site, Chino
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Mengambil pesertaFasa 3
- Clinical Research Site, Chino
Kajian Gangguan Depresi Major di bandar lain
- New York City, NY36 kajian
- Boston, MA31 kajian
- Atlanta, GA25 kajian
- Philadelphia, PA23 kajian
- Orlando, FL19 kajian
- Miami, FL18 kajian
- Chicago, IL17 kajian
- Tampa, FL17 kajian
- San Diego, CA16 kajian
- Houston, TX16 kajian
- Little Rock, AR14 kajian
- Austin, TX13 kajian
Kajian lain di Chino
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.